A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.

Autor:	Hwang, W.Y.K.1,2 ghehyk@sgh.com.sg, Koh, L.-p.1, Ng, H.J.1, Tan, P.H.C.1, Chuah, C.T.H.1, Fook, S.C.3, Chow, H.4, Tan, K.W.4, Wong, C.1, Tan, C.H.1, Goh, Y.-t.1
Zdroj:	Bone Marrow Transplantation. Jul2004, Vol. 34 Issue 1, p51-56. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu